Characterization of the foreign body response of titanium implants modified with polyphenolic coatings
Source abstract
Abstract
Abstract The foreign body response is dictating the outcome of wound healing around any implanted materials. Patients who suffer from chronic inflammatory diseases and impaired wound healing often face a higher risk for implant failure. Therefore, functional surfaces need to be developed to improve tissue integration. For this purpose, we evaluated the impact of surface coatings made of antioxidant polyphenolic molecules tannic acid (TA) and pyrogallol (PG) on the host response in human blood. Our results showed that although the polyphenolic surface modifications impact the initial blood protein adsorption compared to Ti, the complement and coagulation systems are triggered. Despite complement activation, monocytes and granulocytes remained inactivated, which was manifested in a low pro‐inflammatory cytokine expression. Under oxidative stress, both coatings were able to reduce intracellular reactive oxygen species in human gingival fibroblasts (hGFs). However, no anti‐inflammatory effects of polyphenolic coatings could be verified in hGFs stimulated with lipopolysaccharide and IL‐1β. Although polyphenols reportedly inhibit the NF‐κB signaling pathway, phosphorylation of NF‐κB p65 was observed. In conclusion, our results indicated that TA and PG coatings improved the hemocompatibility of titanium surfaces and have the potential to reduce oxidative stress during wound healing.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Oral microbiology and periodontitis research · Bone Tissue Engineering Materials · Wound Healing and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomaterials Institute of Clinical Dentistry, University of Oslo Oslo Norway
Department of Immunology Institute of Clinical Medicine, University of Oslo Oslo Norway
Department of Chemistry and Biomedical Sciences Linnaeus University Kalmar Sweden
Funding
Norges Forskningsråd
References (100+)
Show source-provided references
1. Ratner BD · 2001
2. Biological aspects of implant dentistry: osseointegration
3. Kwakman PHS · 2013
4. 10.1034/j.1600-0501.2000.011S1146.x10.1034/j.1600-0501.2000.011S1146.x ↗
5. Zimmerli W · 2013
6. 10.1002/adhm.20170054910.1002/adhm.201700549 ↗
7. 10.1016/j.actbio.2021.01.00110.1016/j.actbio.2021.01.001 ↗
8. 10.1016/j.biomaterials.2011.05.07810.1016/j.biomaterials.2011.05.078 ↗
9. 10.3390/ijms1101035410.3390/ijms11010354 ↗
10. 10.1021/cr200091610.1021/cr2000916 ↗
11. 10.3390/i809095010.3390/i8090950 ↗
12. 10.1093/jn/133.10.3275S10.1093/jn/133.10.3275S ↗
13. 10.1016/j.cofs.2016.02.00210.1016/j.cofs.2016.02.002 ↗
14. 10.1016/j.bcp.2006.07.00410.1016/j.bcp.2006.07.004 ↗
15. 10.1016/j.colsurfb.2018.03.02910.1016/j.colsurfb.2018.03.029 ↗
16. 10.1016/j.cyto.2018.12.00910.1016/j.cyto.2018.12.009 ↗
17. 10.1016/S0006-2952(99)00335-410.1016/S0006-2952(99)00335-4 ↗
18. 10.1111/j.1600-0722.2007.00415.x10.1111/j.1600-0722.2007.00415.x ↗
19. 10.1016/j.ejphar.2013.10.04710.1016/j.ejphar.2013.10.047 ↗
20. 10.1016/j.fitote.2018.11.01210.1016/j.fitote.2018.11.012 ↗
21. 10.1039/C4CC02961E10.1039/C4CC02961E ↗
22. 10.1098/rsif.2018.079910.1098/rsif.2018.0799 ↗
23. 10.1039/C4TB01616E10.1039/C4TB01616E ↗
24. 10.1002/adhm.20140058710.1002/adhm.201400587 ↗
25. 10.1021/acsbiomaterials.9b0056610.1021/acsbiomaterials.9b00566 ↗
26. 10.1039/D0BM00566E10.1039/D0BM00566E ↗
27. 10.1002/chem.20190235810.1002/chem.201902358 ↗
28. 10.1021/acs.langmuir.6b0195910.1021/acs.langmuir.6b01959 ↗
29. 10.1016/j.molimm.2013.05.22110.1016/j.molimm.2013.05.221 ↗
30. 10.1016/S0891-5849(98)00315-310.1016/S0891-5849(98)00315-3 ↗
31. 10.1021/jf00017a01810.1021/jf00017a018 ↗
32. 10.1002/pmic.20070083310.1002/pmic.200700833 ↗
33. 10.1016/0039-6028(69)90037-510.1016/0039-6028(69)90037-5 ↗
34. 10.1182/blood.V55.1.156.15610.1182/blood.V55.1.156.156 ↗
35. 10.1016/j.jcis.2014.09.07110.1016/j.jcis.2014.09.071 ↗
36. 10.1039/C7CC02411H10.1039/C7CC02411H ↗
37. 10.1016/S0142-9612(98)00201-410.1016/S0142-9612(98)00201-4 ↗
38. 10.1021/acs.jpcb.7b0163710.1021/acs.jpcb.7b01637 ↗
39. 10.1016/j.apsusc.2017.08.13810.1016/j.apsusc.2017.08.138 ↗
40. 10.1021/ja042898o10.1021/ja042898o ↗
41. 10.1016/j.blre.2014.09.00310.1016/j.blre.2014.09.003 ↗
42. 10.1016/j.biomaterials.2009.10.00810.1016/j.biomaterials.2009.10.008 ↗
43. 10.1016/j.actbio.2017.09.03410.1016/j.actbio.2017.09.034 ↗
44. 10.1021/acs.biomac.9b0000610.1021/acs.biomac.9b00006 ↗
45. 10.1126/science.124894310.1126/science.1248943 ↗
46. 10.1016/j.actbio.2012.05.01710.1016/j.actbio.2012.05.017 ↗
47. 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O ↗
48. 10.1016/j.colsurfb.2019.11050510.1016/j.colsurfb.2019.110505 ↗
49. 10.1016/j.imbio.2016.06.00510.1016/j.imbio.2016.06.005 ↗
50. 10.3389/fimmu.2015.0026210.3389/fimmu.2015.00262 ↗
51. 10.3389/fimmu.2015.0025710.3389/fimmu.2015.00257 ↗
52. 10.1111/j.1749-6632.1987.tb33051.x10.1111/j.1749-6632.1987.tb33051.x ↗
53. 10.1016/j.biomaterials.2004.05.01110.1016/j.biomaterials.2004.05.011 ↗
54. 10.1016/S0140-6736(00)02225-X10.1016/S0140-6736(00)02225-X ↗
55. 10.1002/bies.1036010.1002/bies.10360 ↗
56. 10.1016/j.biomaterials.2006.10.02010.1016/j.biomaterials.2006.10.020 ↗
57. 10.1016/j.ensm.2019.07.01810.1016/j.ensm.2019.07.018 ↗
58. 10.1016/j.biomaterials.2009.05.04410.1016/j.biomaterials.2009.05.044 ↗
59. 10.1021/acsami.7b1428110.1021/acsami.7b14281 ↗
60. 10.3109/1745367990900098810.3109/17453679909000988 ↗
61. 10.1160/TH14-12-106710.1160/TH14-12-1067 ↗
62. 10.3389/fimmu.2019.0159010.3389/fimmu.2019.01590 ↗
63. Platelet Surface CD62P and CD63, Mean Platelet Volume, and Soluble/Platelet P‐Selectin as Indexes of Platelet Function in Atrial Fibrillation
64. 10.1016/0014-5793(92)80909-Z10.1016/0014-5793(92)80909-Z ↗
65. 10.1002/ptr.482210.1002/ptr.4822 ↗
66. 10.1021/acsami.0c1694610.1021/acsami.0c16946 ↗
67. 10.1189/jlb.69.4.52210.1189/jlb.69.4.522 ↗
68. 10.1007/BF0236394410.1007/BF02363944 ↗
69. 10.12968/jowc.2013.22.8.40710.12968/jowc.2013.22.8.407 ↗
70. Phenols – Sources and Toxicity
71. 10.1016/S0009-2797(00)00143-510.1016/S0009-2797(00)00143-5 ↗
72. 10.1016/S0308-8146(02)00145-010.1016/S0308-8146(02)00145-0 ↗
73. 10.1111/j.1742-4658.2012.08558.x10.1111/j.1742-4658.2012.08558.x ↗
74. 10.1080/1528739850953077610.1080/15287398509530776 ↗
75. 10.1016/S0278-6915(96)00048-810.1016/S0278-6915(96)00048-8 ↗
76. 10.1002/mnfr.20070000410.1002/mnfr.200700004 ↗
77. 10.1016/j.freeradbiomed.2018.03.01610.1016/j.freeradbiomed.2018.03.016 ↗
78. 10.1016/j.yexcr.2016.08.00710.1016/j.yexcr.2016.08.007 ↗
79. 10.1042/bj263053910.1042/bj2630539 ↗
80. 10.1038/cddiscovery.2015.4610.1038/cddiscovery.2015.46 ↗
81. 10.1164/rccm.220600710.1164/rccm.2206007 ↗
82. 10.1111/j.1432-1033.1993.tb18328.x10.1111/j.1432-1033.1993.tb18328.x ↗
83. 10.1016/0891-5849(94)90182-110.1016/0891-5849(94)90182-1 ↗
84. 10.1016/j.foodchem.2007.05.00610.1016/j.foodchem.2007.05.006 ↗
85. 10.1021/bk-2002-0807.ch01410.1021/bk-2002-0807.ch014 ↗
86. 10.1016/j.freeradbiomed.2008.07.02310.1016/j.freeradbiomed.2008.07.023 ↗
87. 10.1034/j.1399-302x.2000.150305.x10.1034/j.1399-302x.2000.150305.x ↗
88. 10.1111/j.1600-0765.1995.tb01291.x10.1111/j.1600-0765.1995.tb01291.x ↗
89. 10.1007/s00011-019-01282-410.1007/s00011-019-01282-4 ↗
90. 10.1002/biof.119910.1002/biof.1199 ↗
91. 10.1016/j.intimp.2008.08.00110.1016/j.intimp.2008.08.001 ↗
92. 10.1155/2019/628263510.1155/2019/6282635 ↗
93. 10.1016/j.intimp.2007.05.00410.1016/j.intimp.2007.05.004 ↗
94. 10.1038/srep1659310.1038/srep16593 ↗
95. 10.1093/jn/134.5.103910.1093/jn/134.5.1039 ↗
96. 10.1371/journal.pone.013175810.1371/journal.pone.0131758 ↗
97. 10.1111/bph.1233310.1111/bph.12333 ↗
98. 10.1002/jcp.1011910.1002/jcp.10119 ↗
99. 10.1111/j.1365-2567.2004.01976.x10.1111/j.1365-2567.2004.01976.x ↗
100. 10.1016/j.actbio.2021.03.03810.1016/j.actbio.2021.03.038 ↗